Skip to content
Search

Latest Stories

RPS calls on political leaders to end prescription charges for long-term conditions

RPS calls on political leaders to end prescription charges for long-term conditions
RPS and PCC urge political leaders to urgently get rid of prescription charges for chronic conditions on the currently outdated exemption list

In partnership with the Prescription Charges Coalition (PCC), the Royal Pharmaceutical Society (RPS) has taken a significant step by urging political leaders to abolish prescription charges for individuals with long-term conditions.

Tase Oputu, Chair of the RPS England Pharmacy Board, signed an open letter on Thursday, calling on party leaders to address this pressing issue.


The letter emphasises the outdated nature of the current exemption list, which forces individuals with chronic conditions like Parkinson’s, cystic fibrosis, and HIV to bear the cost of their essential medications.

It urges party leaders to urgently review and update the exemption list to ensure equitable access to necessary medicines.

“Nobody should face a financial barrier to accessing the medicines they need," Oputu stated.

"Prescription charges are a stealth tax on health, and every day pharmacists are asked by patients who are unable to afford all the items in their prescription which ones they could 'do without'."

She further highlighted the adverse effects of this financial burden on patients’ health and the broader healthcare system.

“If you can’t afford your medicines, your condition can worsen, leading to poor health, lost productivity, and increased risk of hospital admission, piling pressure on the NHS.

"As the general election approaches, I hope that political parties can commit to scrapping this complex and unjust system,” she added.

Need to revise outdated exemption list

The PCC’s letter to the Conservative and Labour party leaders underscores the urgency of reviewing the exemption list.

It draws attention to the unfairness of the current system, which leaves people with various chronic conditions paying for vital medications necessary for their well-being.

Earlier this week, the Liberal Democrats committed to reviewing the exemption list if elected, as outlined in their manifesto released on June 10th.

This commitment by the Lib Dems has added momentum to the coalition's campaign, with the hope that other parties will follow suit.

The letter, signed by over 20 members of the PCC, sets a compelling case for the new government to revise the outdated exemption list.

The exemption list currently affects individuals with asthma, sickle cell, HIV, cystic fibrosis, Parkinson’s, Crohn’s, and colitis, as well as heart, lung, and kidney diseases.

As the general election draws near, the RPS and PCC are encouraging voters to engage with their local election candidates.

They are urging them to commit to reviewing the prescription exemption list and ensuring that those with long-term conditions receive the necessary medications without financial strain.

The RPS’s call for action highlights a critical public health issue that demands immediate attention from political leaders.

The coalition awaits responses from the party leaders, hopeful for a commitment to end prescription charges and promote equitable healthcare access.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
​The next generation of BD Rowa Smart launched

The latest BD Rowa™ Smart introduces a more intuitive user interface.

Photo credit: BD Rowa

BD Rowa unveils next-generation smart dispensing robot with sustainable design

Leading medical technology company BD Rowa has announced the launch of the next generation of its smart dispensing robot, offering enhanced convenience with a sustainable design.

Currently in its final development phase, the latest BD Rowa™ Smart introduces a more intuitive user interface designed to streamline operations and enhance the user experience.

Keep ReadingShow less